Core Laboratories (CLB) Current Assets (2022 - 2026)

Core Laboratories has reported Current Assets for 5 years, with the latest figure at $214.4 million in Q1 2026.

• For the quarter ending Q1 2026, Current Assets fell 6.29% year-over-year to $214.4 million; the trailing twelve-month figure through Mar 2026 stood at $214.4 million (down 6.29% YoY), and the FY2025 full-year result was $214.7 million, down 3.01% from the prior year.
• Current Assets for Q1 2026 stood at $214.4 million, roughly flat from $214.7 million in the prior quarter.
• The five-year high for Current Assets was $237.7 million in Q2 2025, with the low at $211.7 million in Q4 2022.
• Historically, Current Assets has averaged $226.2 million across 5 years, with a median of $228.5 million in 2023.
• Annual changes were most pronounced in 2023 — Current Assets climbed 5.4% — and 2026, when it decreased 6.29%.
• Core Laboratories' Current Assets stood at $211.7 million in 2022, then gained by 5.4% to $223.1 million in 2023, then retreated by 0.81% to $221.3 million in 2024, then declined by 3.01% to $214.7 million in 2025, then declined by 0.14% to $214.4 million in 2026.
• The last three Current Assets figures came in at $214.4 million (Q1 2026), $214.7 million (Q4 2025), and $226.9 million (Q3 2025), per Business Quant data.